Annapolis dermatology company Alphyn Biologics raises $3.3M, plans $17.5M round By: Baltimore Business Journal via Business Journals September 27, 2022 at 14:56 PM EDT Alphyn Biologics is planning on using its new funding for a clinical trial for its new eczema treatment. Read More >> Related Stocks: Harbor Disruptive Innovation ETF